Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01918306
Title GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Vanderbilt-Ingram Cancer Center
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama Birmingham Alabama United States Details
University of California, San Francisco San Francisco California United States Details
Georgetown University Washington, D.C. District of Columbia United States Details
Emory University Atlanta Georgia United States Details
University of Chicago Chicago Illinois United States Details
Indiana University Indianapolis Indiana United States Details
John Hopkins University Baltimore Maryland United States Details
Dana Farber Cancer Institute Boston Massachusetts United States Details
University of Michigan Ann Arbor Michigan United States Details
Mayo Clinic Rochester Minnesota United States Details
Memorial Sloan-Kettering Cancer Center New York New York United States Details
University of North Carolina Charlotte North Carolina United States Details
University of Pittsburgh Pittsburgh Pennsylvania United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
Baylor Breast Center Houston Texas United States Details
University of Washington Seattle Washington United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field